Neurava, an Indianapolis, IN-based company developing novel and innovative wearable devices, raised $2.26M in Seed funding.
The round was led by Life Science Angels and included a second strategic investment from UCB, in addition to support from Purdue Innovates, Elevate Ventures, Rivermount Ventures, and First Leaf Capital.
Commenting on the news, CTO Vivek Ganesh said: “This funding will allow us to complete a pivotal usability study at leading clinical institutions in adults and pediatric patients with epilepsy. We will also set up manufacturing partners and submit for FDA clearance, in advance of our Series A round of funding.”
Co-founded by CEO Jay Shah and CTO Vivek Ganesh, Neurava is a MedTech startup developing smart wearables capable of identifying and alerting for seizures, cardiorespiratory dysfunctions, and impending SUDEP risk. This diagnostic platform can have a lifesaving impact on people worldwide who suffer from epilepsy.
FinSMEs
05/04/2024